Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0191120180330430277
Journal of Korean Medical Science
2018 Volume.33 No. 43 p.277 ~ p.277
Partial versus Radical Nephrectomy for T1-T2 Renal Cell Carcinoma in Patients with Chronic Kidney Disease Stage III: a Multiinstitutional Analysis of Kidney Function and Survival Rate
Chung Jae-Seung

Son Nak-Hoon
Lee Sang-Eun
Hong Sung-Kyu
Jeong Chang-Wook
Kwak Cheol
Kim Hyeon-Hoe
Hong Sung-Hoo
Kim Yong-June
Kang Seok-Ho
Chung Jin-Soo
Kwon Tae-Gyun
Hwang Eu-Chang
Byun Seok-Soo
Abstract
Background: To examine survival rates and renal function after partial nephrectomy (PN) and radical nephrectomy (RN) in patients with chronic kidney disease (CKD).

Methods: We studied 4,332 patients who underwent PN or RN for pathological T1a-T2N0M0 renal cell carcinoma from 1988 to 2014. Patients were divided into two subgroups of CKD stage I?II and stage III. Kidney function, and survival outcomes were compared between groups.

Results: We included 1,756 patients with CKD I?II and 276 patients with CKD III in the final pair-matched analysis. Kidney function was significantly better preserved in the PN than in the RN group among all patients. However, the beneficial effect of PN on kidney function gradually disappeared over time in CKD III patients. The 5-year overall survival (OS) rates after PN and RN differed in patients with CKD I?II disease (99.4% vs. 96.5%, respectively, P = 0.015). The 5-year OS rates after surgery were not affected by mode of nephrectomy in CKD III patients (97.8% vs. 93.5%, P = 0.103). The 5-year cancer-specific survival rates did not differ between treatment groups in all CKD stage. Cox hazard analysis showed that the operative method was a significant factor for OS in CKD I?II patients (hazard ratio [HR], 0.320; confidence interval [CI], 0.122?0.840; P = 0.021). However, PN was not beneficial in terms of OS in CKD III patients (HR, 0.395; CI, 0.086?1.172; P = 0.117).

Conclusion: PN is associated with a higher OS rate and better kidney function in patients with preoperative CKD stage I and II, but not in those with CKD stage III.
KEYWORD
Carcinoma, Renal Cell, Survival, Nephrectomy, Renal Insufficiency
FullTexts / Linksout information
 
Listed journal information
SCI(E) MEDLINE ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø